Boston Biochem Inc Cambridge, MA - 02139

Boston Biochem Inc is categorized under Protein Analyzers, Laboratory Type in Cambridge, MA and active since 2011.

Boston Biochem Inc was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Protein Analyzers, Laboratory Type business, which does work in the B2B market, and is classified as a Protein Analyzers, Laboratory Type, under code number 5417110 by the NAICS.

If you are seeking more information, feel free to contact Francesco Melandri, President at the company’s branch by writing to 840 Memorial Drive # 3, Cambridge, Massachusetts MA 02139 or by phoning (617) 241-7072. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Boston Biochem Inc
Contact Person: Francesco Melandri, President
Address: 840 Memorial Drive # 3, Cambridge, Massachusetts 02139
Phone Number: (617) 241-7072
Website Address: bostonbiochem.com
Annual Revenue (USD): Unknown
Founded: 2011
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Protein Analyzers, Laboratory Type
SIC Code: 3826
NAICS Code: 5417110
Share This Business:

Boston Biochem Inc was started in 2011 to provide professional Protein Analyzers, Laboratory Type under the SIC code 3826 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Francesco Melandri, President for inquiries that concern Boston Biochem Inc by calling the company number (617) 241-7072, as your correspondence is most welcome. Additionally, the physical location of the branch of Boston Biochem Inc can be found at the coordinates 42.36246,-71.11598 as well as the street address 840 Memorial Drive # 3 in Cambridge, Massachusetts 02139.

For its online presence, you may visit Boston Biochem Inc’s website at bostonbiochem.com and engage with its social media outlets through on Twitter and on Facebook.